Patent Application
20120058511
1) Field of the Invention
The present invention relates to a mutant microorganism and a method for producing peptides using the mutant microorganism. More particularly, the present invention relates to the mutant microorganism that allow for efficient production of the peptides and the method for producing the peptides using the mutant microorganism.
2) Description of the Related Art
Peptides are used in various fields such as pharmaceuticals and foods. For example, L-alanyl-L-glutamine is widely used as components of solutions for transfusion and of serum-free media, because it is more stable and soluble in water than L-glutamine.
The peptides are generally produced by chemical synthetic methods. However, such methods often require complicated and inefficient steps, none of which are fully satisfactory.
On the other hand, methods for producing peptides with enzymes have also been developed. However, the conventional methods with enzymes require improvement of extremely slow rate of peptide formation, low yield of peptide formation, and so forth. Therefore, development of a novel method for producing such peptides on an industrial scale and at a high efficiency has been demanded.
The method for efficiently producing target products using microorganisms has been disclosed, which involves steps for preparing a strain disrupted of which a gene for enzyme catalyzing a reaction with the target product as a substrate, and producing the target products using them (for example, JP-A No. 2003-189863).
The method for producing the target products by preparing disrupted strains does not achieve efficient production, because its yield decreases unless enzymes, which involve in a reaction system from starting microorganisms to target products and are factors that mediate production of byproducts and decompose the target products, are appropriately disrupted. However, the reaction system including microorganisms is often complicated and thereby, it is difficult to find appropriate genes to be disrupted depending on conditions such as materials, the target products, and kinds of microorganisms to be used.
Thus, an object of the present invention is to provide a method for efficiently producing peptides using disrupted strains.
As a result of extensive studies, the inventors of the present invention have found the genes to be disrupted to achieve efficient production of peptides using microorganisms, thus accomplishing the present invention. The present invention provides the mutant microorganisms, the method for preparing them, and the method for producing peptides, all of which are in detail explained below.
1. A mutant microorganism of which at least one gene is disrupted,
wherein the gene is selected from the group consisting of a gene encoding aminoacylhistidine peptidase, a gene encoding leucylaminopeptidase and a gene encoding isoaspartyldipeptidase, respectively on a chromosome.
2. The microorganism according to item 1, of which a gene encoding α-aspartyldipeptidase on the chromosome is disrupted.
3. The microorganism according to item 1 or 2, which is a bacterium belonging to the genus Escherichia.
4. A mutant microorganism:
of which at least one gene is disrupted, wherein the gene is selected from the group consisting of a gene encoding aminoacylhistidine peptidase, a gene encoding leucylaminopeptidase and a gene encoding isoaspartyldipeptidase, respectively on a chromosome; and
which is transformed with a recombinant DNA including a polynucleotide encoding a protein having peptide-synthesizing activity.
5. The microorganism according to item 4, of which a gene encoding α-aspartyldipeptidase on the chromosome is disrupted.
6. The microorganism according to item 4 or 5, which is a bacterium belonging to a genus Escherichia.
7. The microorganism according to any of items 4 to 6, wherein the protein having peptide-synthesizing activity is derived from the bacterium belonging to the genus Empedobacter or Sphingobacterium.
8. The microorganism according to any one of items 4 to 6, wherein the protein having the peptide-synthesizing activity is selected from the group consisting of (A) and (B):
(A) a protein comprising an amino acid sequence of SEQ ID NO: 14,
(B) a protein comprising an amino acid sequence including substitution, deletion, insertion, addition, and/or inversion of one or several amino acid residues in the amino acid sequence of SEQ ID NO: 14, and having the peptide-synthesizing activity.
9. The microorganism according to any one of items 4 to 6, wherein the protein having the peptide-synthesizing activity is selected from the group consisting of (C) or (D):
(C) a protein comprising an amino acid sequence of SEQ ID NO: 20,
(D) a protein comprising an amino acid sequence including substitution, deletion, insertion, addition, and/or inversion of one or several amino acid residues in the amino acid sequence of SEQ ID NO: 20, and having the peptide-synthesizing activity.
10. A method for producing a microorganism comprising:
disrupting at least one gene selected from the group consisting of a gene encoding aminoacylhistidine peptidase, a gene encoding leucylaminopeptidase and a gene encoding isoaspartyldipeptidase, respectively on a chromosome.
11. The method for producing a microorganism according to item 10, comprising:
disrupting a gene encoding α-aspartyldipeptidase on the chromosome.
12. A method for producing a microorganism comprising:
disrupting at least one gene selected from the group consisting of a gene encoding aminoacylhistidine peptidase, a gene encoding leucylaminopeptidase and a gene encoding isoaspartyldipeptidase, respectively on a chromosome; and
transforming with a recombinant DNA including a polynucleotide encoding a protein having peptide-synthesizing activity.
13. The method for producing a microorganism according to item 12, comprising:
disrupting a gene encoding α-aspartyldipeptidase on the chromosome.
14. A method for producing a peptide comprising:
cultivating in medium a microorganism of which at least one gene is disrupted, wherein the gene is selected from the group consisting of a gene encoding aminoacylhistidine peptidase, a gene encoding leucylaminopeptidase and a gene encoding isoaspartyldipeptidase, respectively on a chromosome, and wherein the microorganism is transformed with a recombinant DNA including a polynucleotide encoding a protein having peptide-synthesizing activity; and
mixing at least one of the microorganism cultivated and a disrupted cell of the microorganism with a carboxy component and an amine component to form a peptide.
15. The method for producing a peptide according to item 14,
wherein a gene encoding α-aspartyldipeptidase on a chromosome of the microorganism is disrupted.
According to the present invention, the method for effectively producing the peptides may be provided. The present invention is very useful in industrial production of the peptides.
Embodiments are explained below referring to best modes for carrying out the present invention. Note that various gene engineering techniques described below are disclosed in many typical experimental manuals including Molecular Cloning, 2nd edition, Cold Spring Harbor press (1989), Cell technology Handbook(Saibokogaku Handbook), Toshio Kuroki et al., Yodosya (1992), and New Gene Engineering Handbook(Shin-Idenshikogaku Handbook) Revision 3, edited by Muramatsu et al., Yodosya (1999). The descriptions of them are quoted in this specification.
1. Mutant microorganisms of the present invention and the method for producing them
The microorganisms of the present invention are produced by disrupting genes that prevent efficient formation of the peptides. The genes to be disrupted include a gene encoding aminoacyl histidinepeptidase(hereinafter, simply referred to as “pepD gene”), a gene encoding leucylaminopeptidase(hereinafter, “pepA gene”), and a gene encoding isoaspartyldipeptidase(hereinafter, “iadA gene”), all of which express in microorganism chromosomes. At least one of genes among these genes may be disrupted. Moreover, the microorganisms of the present invention may be exemplified as a more preferable embodiment than that of the microorganisms produced by disrupting a gene encoding α-aspartyldipeptidase(hereinafter, “pepE gene”) on the chromosome.
The use of microorganisms produced by disrupting one or more of genes among the aforementioned gene group achieves more efficient peptide production than the use of microorganisms, in which these genes express. It is considered that the efficient production of the target peptides is achieved in this way, mainly because decomposition activity of the peptides, namely the target products, can be decreased or inhibited.
The genes referred in this specification are medium having genetic codes including, for example, polypeptides having nucleotide sequences encoding proteins.
In this specification, the disruption of a gene refers to the suppression or inhibition of the expression of gene products. More specifically, the genes may be disrupted by inducing mutation in the genes encoding peptidase having activity of decomposing peptides, namely target products, or by deleting the same genes. A specific method for disrupting genes is further explained later in this specification.
In this specification, “peptide” refers to a polymer having a peptide bond, namely a polypeptide including, for example, a dipeptide, a tripeptide, and an oligopeptide.
A preferable embodiment of the present invention includes a mode, wherein among these genes, at least a pepD gene is disrupted. The disruption of the pepD gene may significantly improve efficiency of peptide production, and is outstandingly effective, especially in the production of aspartylphenylalanine, alanylglutamine, and so forth. Further preferable embodiment includes a mode, wherein all of the pepD, pepA, iadA, and pepE genes are disrupted. When all four kinds of genes are disrupted, it is most probable that the decomposition and deletion of produced peptides can be inhibited in producing each kind of peptide.
The kinds of microorganisms of the present invention are not limited to those referred herein and may be any kind of microorganisms that can be used in peptide production. In this specification, the microorganisms may include eucaryotic microorganisms, prokaryotic microorganisms, and viruses. From the viewpoint of application to industrial production, easiest-to-treat bacteria are preferable, enterobacteria are further preferable, and particularly, bacteria that belong to the genus Escherichia, of which typical microorganism is Escherichia coli, are furthermore preferably exemplified.
Now, giving an example of a mode, wherein decomposition activity of alanyl-glutamine and aspartylphenylalanine is decreased or deactivated, the method for preparing the strains of disrupted genes is more specifically explained. The decomposition activity of alanylglutamine and aspartylphenylalanine may be decreased or deactivated by inducing mutation in the gene encoding each of peptidases or by deactivating the expression of the gene, so that the activity of peptidases acting on alanylglutamine and aspartylphenylalanine as well as their derivatives may be decreased or deactivated in cells. To deactivate peptidase genes, commonly-used techniques can be used including UV irradiation, mutation induction process with nitrosoguanidine (N-methyl-N′-nitro-N-nitrosoguanidine), site-specific mutation, homologous replacement, and/or gene disruption using insertion-deletion mutation also called “Red-driven integration” (Datsenko K. A. and Wanner B. L., Proc. Natl. Acad. Sci. USA, 2000, Vol. 97, No. 12, p6640-45).
The Peptidases that decompose alanylglutamine and aspartylphenylalanine as well as their derivatives include; aminoacylhistidine dipeptidase encoded by a pepD gene; α-aspartyldipeptidase encoded by a pepE gene; leucylaminopeptidase encoded by a pepA; and isoaspartyldipeptidase encoded by an iadA gene. It has been known that the pepD, pepE, pepA, and iadA genes are contained in the microorganisms, for example, Escherichia coli (pepD Gene; J. Bacteriol. 172 (8), 4641-4651 (1990), pepE Gene; JP-A No. 189863/2003, pepA Gene; J Mol. Biol. 2000 Sep. 15; 302(2):411-26, iadA Gene; J Biol. Chem. 1995 Feb. 24; 270(8):4076-87). The deficient strain lacking each peptidase gene may be obtained by, for example, homogeneously recombining the DNA fragment containing a region of each gene with its corresponding gene on the chromosome of the microorganism to integrate them into the chromosome DNA.
Specifically, peptidase genes on the chromosome may be deleted by, for example, transforming microorganisms such as Escherichia coli with the DNA containing the deficient peptidase gene, wherein the region of the peptidase gene has been deleted to alter so that normally working peptidase may be prevented from being produced, which induces recombination of the deficient peptidase gene with the peptidase gene on the chromosome. The method for deleting genes using the aforementioned homologous replacement technique has been well-established. Alternatively, the gene may be deleted by any of the methods using a liner DNA and using plasmid containing temperature-sensitive replication origin, and/or by the insertion-deletion mutation method also called “Red-driven integration”. The method using plasmid containing the temperature-sensitive replication origin and the insertion-deletion mutation method also called “Red-driven integration” are explained below.
The nucleotide sequences of pepD, pepE, pepA, and iadA genes encoding peptidases contained in Escherichia coli have been registered in DDBJ/EMBL/GenBank International Nucleotide Sequence Database with accession numbers AE000132, AE000475, AE000496, and AE000503 assigned, respectively. It is possible to obtain fragments of each gene by synthesizing primers based on these nucleotide sequences and replicating them using chromosome DNAs of Escherichia bacteria, for example, Escherichia coli W3110 strain as templates by a Polymerase Chain reaction (PCR; White, T. J. et al., Trends Genet., 5,185 (1989)).
Then, the DNA containing the gene, wherein some part of the nucleotide sequence thereof has been lost (deficient peptidase gene) to alter so that normally-working peptidase may be inhibited from being produced using the obtained peptidase gene as a material. To replace this deficient peptidase gene for the peptidase gene expressed on the host chromosome, the procedure described below is followed. That is, the transformed strain, wherein the recombinant DNA has been integrated into the chromosome DNA by following the steps for; incorporating the temperature-sensitive replication origin, the mutant peptidase gene, and the marker gene having resistance to antibiotics such as ampicillin, kanamycin, tetracycline and chloramphenicol to prepare the recombinant DNA; transforming the obtained recombinant DNA; cultivating the transformed strain at such a temperature that the temperature-sensitive replication origin is not activated; and cultivating the strain in the medium.
The strain having the recombinant DNA integrated in the chromosome in this way has been replaced for a native peptidase gene sequence on the chromosome and two fusion genes coupling the chromosome peptidase gene and the deficient peptidase gene are contained in the chromosome with the remaining region of the recombinant DNA (a vector region, the temperature-sensitive replication origin, and the drug-resistance marker) laid between them. Thus, since the normal peptidase gene has dominance in this state, the peptidase expresses in the transformed strain.
Second, to keep only the deficient peptidase gene on the chromosome DNA, two peptidase genes are recombined to remove one copy of peptidase gene with the vector region (including the temperature-sensitive replication origin and the drug-resistance marker) from the chromosome DNA. Note that in some cases, the normal peptidase genes may remain on the chromosome DNA and the deficient peptidase genes may be separated, while in other cases, the deficient peptidase genes may be left on the chromosome gene and the normal peptidase genes may be separated. In any case, the cultivation of the transformants at such a temperature that the temperature-sensitive replication origin is activated allows the separated DNA to remain in the cell in the state of plasmid.
Third, the cultivation of the transformants at such a temperature that the temperature-sensitive replication origin is not activated, decreases or inhibits the peptidase activity because plasmid containing the deficient peptidase genes is removed, if the deficient peptidase genes remain on the chromosome DNA, while peptidase activity is activated if the normal peptidase genes remain on the chromosome DNA. The target strain may be selected by amplifying the fragment containing the peptidase genes from the chromosome DNA of a candidate strain through Polymerase Chain Reaction (PCR) and by verifying that the peptidase genes have been knockout by restriction endonuclease analysis.
Alternatively, the target peptidase genes may be deleted by the Red-driven integration method (Proc. Natl. Acad. Sci. USA, 2000, vol. 97, No. 12, p6640-6645). According to the method described in the publication, primers are designed having complementary sequence to the region in the vicinity of each of genes; the peptidase gene; and the gene providing antibiotic-resistance to the template plasmid. For example, PCR is performed using the plasmid pACYC184 (NBL Gene Sciences Ltd. (England), GenBank/EMBL Accession No. X06403) as the template and the primers complementary to the region in the vicinity of each of the genes; the peptidase gene; and the gene for providing chloramphenicol-resistance to the template plasmid; to prepare the gene inserted the gene for providing chloramphenicol-resistance into the peptide gene to be deleted. Then, the resultant PCR product is purified in agarose gel and using this purified product, Escherichia coli containing plasmid pKD46 having an ability to replicate the temperature-sensitivity property is transformed by electroporation. Plasmid pKD46 (Proc. Natl. Acad. Sci. USA, 2000, vol. 97, No. 12, p6640-6645) contains the DNA fragment GenBank/EMBL accession Nos. J02459, 31088th to 33241th) of 2154 nucleotides of λ phage containing the genes (λ, β, and exo genes) in a λRed homologous recombinant system controlled by an arabinose-derivative ParaB promoter. Plasmid pKD46 is necessary to integrate the PCR product into the chromosome of Escherichia coli.
Competent cells for electroporation may be prepared in the method mentioned below. Specifically, Escherichia coli, that has been cultivated overnight in the LB medium containing 100 mg/L of ampicillin at 30° C., is 100-fold diluted with 5 mL of SOB medium (Molecular Cloning: Laboratory Manual 2nd version, Sambrook, J. et al., Cold Spring Harbor Laboratory Press (1989)) containing ampicillin and L-arabinose (1 mM). The resultant diluted solution may be used in electroporation by following the steps for; growing the cells at 30° C. until OD600 reaches an approximate point of 0.6 while aerating; concentrating the solution to a 100-fold concentration; and rinsing the cells with deionized water cooled on ice three times. The mutant microorganisms with the peptidase genes deleted may be obtained through an insertion-deletion mutation process, wherein electroporation is performed using 70 μL of competent cells and approximately 100 ng of PCR products, the cells are plate-cultured in the L-agar medium containing chloramphenicol at 37° C. and a chloramphenicol-resistant recombinant is selected. Moreover, pKD46 plasmid may be removed by cultivating the obtained recombinant in the L-agar medium containing chloramphenicol over two generations at 42° C. and selecting a colony with the ampicillin-resistance lost.
As to the mutant with the peptidase gene deleted, which has been obtained in the manner mentioned above and may be identified by the chloramphenicol-resistant gene, the target strain may be confirmed by amplifying the fragment containing the peptidase genes from the chromosome DNA of a candidate strain through PCR and by verifying that the peptidase genes have been deleted by the method such as restriction endonuclease analysis. Thus, the strains with the genes disrupted may be prepared.
According to another preferable embodiment of the present invention, the microorganism, which has been transformed by further introducing the recombinant DNA containing polynucleotide encoding proteins having peptide-synthesizing activity into the gene disrupted strain, which have been prepared in the aforementioned manner, may be obtained. According to further another preferable embodiment of the present invention, the proteins derived from a bacterium belonging to the genus of Empedobacter brevis or Sphingobacterium is used as the proteins having peptide-synthesizing activity. More specifically, it is preferable that one or more of proteins selected from the group consisting of proteins (A) to (D) mentioned below are used. The proteins of groups (A) to (D) mentioned below have superior peptide-synthesizing activity. Moreover, the proteins of (A) to (D) groups are suitable for forming peptides such as aspartylphenylalanine and alanylglutamine.
(A) a protein comprising an amino acid sequence consisting of amino acid residues numbers 23-616 of an amino acid sequence in SEQ ID NO: 14
(B) a protein comprising an amino acid sequence including substitution, deletion, insertion, addition, and/or inversion of one or several amino acid residues in the amino acid sequence consisting of amino acid residues numbers 23-616 of an amino acid sequence in SEQ ID NO: 14, and having the peptide-synthesizing activity
(C) a protein comprising an amino acid sequence consisting of amino acid residues numbers 21-619 of an amino acid sequence in SEQ ID NO: 20
(D) a protein comprising an amino acid sequence including substitution, deletion, insertion, addition, and/or inversion of one or several amino acid residues in the amino acid sequence consisting of amino acid residues numbers 21-619 of an amino acid sequence in SEQ ID NO: 20, and having the peptide-synthesizing activity.
An entire range of amino acid sequences categorized in SEQ ID NO: 14 contains a leader peptide and a mature protein domain, the leader peptide consisting of amino-acid residues with NOs. 1 to 22 and the mature protein domain consisting of those with NOs. 23 to 616.
An entire range of amino acid sequences categorized in SEQ ID NO: 20 contains the leader peptide and the mature protein domain, said leader peptide consisting of amino-acid residues with NOs. 1 to 20 and said mature protein domain consisting of those with NOs. 21 to 619.
Herein, the term “several” refers to the number of amino acids within a range, which have less effect on the three-dimensional structure of the protein composed of amino-acid residues and the activity of the protein. It may be depending on the location and the types of amino-acid residues in the three-dimensional structure of the protein, and the range is specifically 2 to 50, preferably 2 to 30, and several preferably 2 to 10. Note that it is desirable that among those of protein groups (B) and (D), the protein comprising the amino-acid sequence containing substitution, deletion, insertion, addition, and/or inversion of one or several amino acid residues, retain approximately 50% or more, preferably 80% or more, and more preferably 90% or more of enzyme activity of the protein comprising no mutation under the conditions, 50° C. and pH8. Giving the amino acid sequence in SEQ ID. NO: 6, (B) as an example, the protein comprising amino acid sequence containing substitution, deletion, insertion, addition, and/or inversion of one or several amino acid residues, desirably retain approximately 50% or more, preferably 80% or more, and more preferably 90% or more of enzyme activity of the protein comprising the amino acid sequence in SEQ ID. NO: 6 under the conditions, 50° C. and pH8.
The mutation in amino acids as shown in the aforementioned (B) may be induced by modifying the nucleotide sequence so that the amino acids at the corresponding sites of the enzyme gene may be substituted, deleted, inserted, and/or added using, for example, the site-specific mutation method. Alternatively, the polynucleotide having modified nucleotide sequence may be obtained by the conventionally known the mutation process. The mutation process may include a technique involving a step for in vitro inducing the mutation in the DNA encoding the amino acids of the (A) or (C) under the treatment of hydroxylamine and a technique involving a step for introducing the mutation in a bacterium belonging to the genus Escherichia containing the DNA encoding the amino acids of the (A) or (C) group by UV irradiation, or under the treatment with methyl-N′-nitro-N-nitrosoguanidine(NTG) or any of mutating agents generally used for mutation engineering, such as nitrous acid.
The mutations such as the aforementioned substitution, deletion, insertion, addition and/or inversion in nucleotides include inherent mutation induced by a difference among the species of microorganisms or the strains and mutation induced naturally. By causing the DNA having the aforementioned mutation in an appropriate cell to express to examine the enzyme activity of an expressing product, the DNA encoding the substantially same protein as those categorized in SEQ ID NO: 14 or 20 in the Sequence Listing may be obtained.
The amino acid sequence contained in the aforementioned proteins of the (A) is encoded based on, for example, the nucleotide sequences SEQ ID NO: 13. The DNA consisting of the nucleotide sequences with BASE NOs. 61˜1908 in SEQ ID NO: 13 has been isolated from Empedobacter brevis FERM BP-8113 strain deposited at International Patent Organism Depository, the National Industrial Research Institute (1-1 Chuoh 6, Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan) on Jul. 8, 2002.
The DNA consisting of the nucleotide sequences with BASE NOs. 61˜1908 in SEQ ID NO: 13 corresponds to a code sequence (CDS) region. The nucleotide sequence with BASE NOs. 61˜1908 contain the signal sequence and mature protein domains. The signal sequence domain is a region ranging from BASE NOs. 61 to 126 and the mature protein domain is a region ranging from BASE NOs. 127 to 1908. Namely, the present invention provides both of peptide enzyme protein genes containing the signal sequence and peptide enzyme protein genes as mature proteins. The signal sequence included in the nucleotide sequence in SEQ ID NO: 13 is one kind of leader sequence, wherein the main function of the leader peptide encoded by the leader sequence is possibly to cause peptide to be secreted out of a cell membrane from inside of the cell membrane. The protein encoded based on BASE NOs. 127 to 1908, which is the region excluding the leader peptide, corresponds to the mature protein which possibly has high peptide-synthesizing activity.
The amino acid sequence contained in the aforementioned protein of (C) is encoded based on, for example, the nucleotide sequences in SEQ ID NO: 19. The DNA consisting of the nucleotide sequence with BASE NOs. 61 to 1917 categorized in SEQ ID NO: 19 has been isolated from Sphingobacterium SP FERM BP-8124 strain deposited at International Patent Organism Depository, the National Industrial Research Institute (1-1 Chuoh 6, Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan) on Jul. 22, 2002. The DNA consisting of the nucleotide sequences with BASE NOs. 61 to 1917 in SEQ ID NO: 11 corresponds to the code sequence (CDS) region.
The nucleotide sequence with BASE NOs. 61 to 1917 contains the signal sequence and mature protein domains. The signal sequence domain is a region ranging from BASE NOs. 61 to 120 and the mature protein domain is a region ranging from BASE NOs. 121 to 1917. Namely, the present invention provides both of the peptide enzyme protein gene containing the signal sequence and the peptide enzyme protein gene as a mature protein. The signal sequence included in the nucleotide sequence in SEQ ID NO: 19 is one kind of leader sequence, wherein the main function of the leader peptide encoded in the leader sequence domain is possibly to cause the peptide to be secreted out of the cell membrane from inside of the cell membrane. The protein encoded based on BASE NOs. 121 to 1917, which is the region excluding the leader peptide, corresponds to the mature protein which possibly has high peptide-synthesizing activity.
The DNA of SEQ ID NO: 13 and the DNA of SEQ ID NO: 19 may be obtained from the chromosome DNAs of Empedobacter brevis and Sphingobacterium SP, or DNA libraries, respectively through PCR (polymerase chain reaction, refer to White, T. J. et al; Trends Genet., 5, 185 (1989)) or hybridization. The primers to be used in PCR may be designed by using internal amino acid sequences determined based on the purified protein having peptide-synthesizing activity. In addition, a probe for hybridization other than the primer may be designed, and the DNA of SEQ ID NOs:13 and 19 may be isolated using each probe. Using the primers having the sequences corresponding to 5′ and 3′ non-translation domains, respectively, as those for PCR, the whole length of encoding domain of the protein may be amplified. Giving as an example such a case that the domain containing both the leader sequence and mature protein encoding domains is amplified, specifically, the primers for PCR may include the primer having nucleotide sequences in the upstream of the nucleotide sequence with BASE NOs. 61 in SEQ ID NO: 13 for the primer on the 5′ side and the primer having nucleotide sequences complementary to those in the downstream of the nucleotide sequence with BASE NOs. 1908 as the primer for the 3′ side.
The primer may be synthesized by, for example, the phosphoramidite method (refer to Tetrahedron Letters (1981),22,1859) using a DNA synthesizer model 380B supplied from Applied Biosystems in the usual manner. The PCR may be performed by the method specified by the suppliers, for example, the manufacturers of Gene Amp PCR System 9600 (PERKIN ELMER) and TaKaRa LA PCR in vitro Cloning Kit (TaKaRa).
In addition to the DNA having nucleotide sequence in SEQ ID NO: 13, the DNA substantially the same as that composed of CDS in SEQ ID NO: 13 may be used, regardless of the presence of the leader sequence. Namely, substantially the same DNA in SEQ ID NO: 13 may be also obtained from the DNA encoding the enzyme having the mutation or the cell retaining this DNA by hybridizing with the probe, which is prepared the DNA consisting of the nucleotide sequence complementary to CDS in SEQ ID NO: 13 or the same nucleotide sequence under a stringent condition, and by isolating the DNA encoding the proteins having the peptide-synthesizing activity.
In addition to the DNA having nucleotide sequence in SEQ ID NO: 19, the DNA substantially the same as that composed of CDS in SEQ ID NO: 19 may be used, regardless of the presence of the leader sequence. Namely, substantially the same DNA in SEQ ID NO: 19 may be also obtained from the DNA encoding the enzyme having the mutation or the cell retaining this DNA by hybridizing under a stringent condition with the probe, which is prepared based on the DNA consisting of the nucleotide sequence complementary to CDS in SEQ ID NO: 19 or the same nucleotide sequence, and by isolating the DNA encoding the proteins having the peptide-synthesizing activity.
The probe may be prepared based on, for example, the nucleotide sequence in SEQ ID NO: 19 in the usual manner. Alternatively, for a target DNA to be isolated, the prove is used to hybridize with and probe the DNA in the usual way. For example, the DNA probe may be prepared by amplifying the nucleotide sequence cloned into the plasmid or phage vector, followed by separation and extraction of the nucleotide sequence to be used as the prove with restriction enzyme. The site, at which the nucleotide sequence is separated, may be regulated depending on the target DNA.
The term “under a stringent condition” as used herein refers to a condition under which a so-called specific hybrid is formed but no non-specific hybrid is formed. It is difficult to precisely express this condition in numerical values. For example, mention may be made of a condition under which DNAs having a high homology, for example, 50% or more, preferably 80% or more, more preferably 90% or more, hybridize with each other and DNAs having a lower homology than these do not hybridize with each other, or ordinary conditions for rinse in southern hybridization under which hybridization is performed at 60° C. in a salt concentration corresponding to 1×SSC and 0.1% SDS, preferably 60° C., 0.1×SSC, and 0.1% SDS. The activity of peptide-synthesizing enzyme is as already explained above. In some of genes hybridized under any of these conditions, a stop codon may exist in the sequence or their activity may be lost due to the mutation at an active center. These genes may be easily removed by coupling them to the vectors commercially available, which causes them in an appropriate host to express, followed by determining the enzyme activity of an expressing product in the manner mentioned later.
However, in the case of the nucleotide sequence that hybridizes with a complementary nucleotide sequence under a stringent condition, it is desirable that the protein encoded thereby retain an enzyme activity of 10% or more, more preferably 50% or more of the enzyme activity of the protein having the original amino acid sequence be retained under conditions of 50° C. and pH 8. For example, the nucleotide sequence, which is hybridized under the stringent condition with a DNA consisting of nucleotide sequence complementary to the nucleotide sequence with BASE NOs. 127 to 1908 in SEQ ID NO: 9 are provided as an example. It is desirable that the DNA retains the enzyme activity in approximately 50% or more, preferably 80% or more, and more preferably 90% or more of the protein having the amino acid sequences with amino-acid residue NOs. 23 to 616 in SEQ ID NO: 6 under the conditions, 50° C. and pH8.
The method for producing the microorganisms transformed so that the proteins aforementioned in (A) or (C) may express. The transformant, which may express the protein aforementioned in (A) or (C) having the peptide-synthesizing activity, may be formed by, for example, introducing the DNA having nucleotide sequence in SEQ ID NO: 13 or 19 into an appropriate host to allow them to express.
The host, which may be used as the host where the protein identified by the DNA having nucleotide sequence in SEQ ID NO: 13 or 19 express, may include any of bacteria of the genera of Escherichia such as Escherichia coli, of Empedobacter, of Sphingobacterium, and of Flavobacterium; a wide variety of procaryotic cells including Bacillus subtilis; and a wide variety of eucaryotic cells including Saccharomyces cerevisiae, Pichia stipitis, and Aspergillus oryzae.
The recombinant DNA, which is used to introduce the DNA having nucleotide sequence in SEQ ID NO: 13 or 19 into the host, may be prepared by introducing the DNA into the appropriate vector depending on the type of the host in such a mode that the protein to be encoded by the DNA may express. For a promoter, which mediates protein expression, the specific promoter for the peptide-synthesizing enzyme gene in the microorganism such as Empedobacter brevis, may be used, provided that it works normally in the host cell. Alternatively, if necessary, any other promoter, which works normally in the host cell, may be ligated to the DNA in SEQ ID NO: 13 or 19 to allow the proteins to express under the control of the promoter.
The transformation method for introducing the recombinant DNA into the host cell includes the D. M. Morrison's method (Methods in Enzymology 68, 326 (1979)) and the method involving treating recipient bacterium cells with calcium chloride to enhance DNA permeability (Mandel, M. and Higa, A., J. Mol. Biol., 53,159 (1970)).
When a protein is mass-produced by using the recombinant DNA technology, a preferable embodiment includes a mode in which the protein molecules associate to form inclusion body of protein in the transformant that produces the protein. This expression production method has an advantage, for example, in that the target protein is protected from digestion by proteases that exist in the microbial cells and that the target protein can be easily purified by disrupting the microbial cells and subsequent centrifugation operation.
The inclusion body of protein thus obtained is solubilized with a protein modifier and converted into a physiologically active protein that is properly folded after passing through an activating reconstitution operation by removing the modifier. There are many examples including, for example, activating reconstitution of human interleukin-2 (JP 61-257931A).
To obtain an activated type protein from the inclusion body of protein, a series of operations such as solubilization and activating reconstitution are necessary, so that the operation becomes more complicated than the case in where the activated type protein is directly produced. However, in the case where a protein that influences on the growth of microbial cells is mass-produced in the cells, the influence may be suppressed by allowing the protein to be accumulated in the cells in the form of an inactive inclusion body of protein.
The method in which a target protein is mass-produced as an inclusion body includes a method in which the target protein is allowed to be expressed alone under control of a potent promoter, and a method in which the target protein is allowed to be expressed as a fused protein with a protein whose mass expression has been known.
Giving an example, a method, which involves a step for preparing transformed Escherichia coli followed by preparing the peptide-synthesizing enzyme using the same bacterium, is more specifically mentioned below. Note that to allow the microorganisms such as Escherichia coli to form the peptide-synthesizing enzyme, the DNA, which encodes a precursor protein containing a leader sequence, may be combined as a protein coding sequence or only the DNA in the mature protein domain with no leader sequence contained may be combined. Any of these methods may be selected at one's discretion taking into account the conditions for production and usage, and the morphology of the enzyme to be produced and other factors.
For the promoter, which mediates the expression of the DNA encoding the proteins having the peptide-synthesizing activity, the promoter may be usually used in producing heterogeneous proteins in the microorganism of Escherichia coli. The promoter includes powerful promoters such as T7 promoter, lac promoter, trp promoter, trc promoter, tac promoter, PR promoter of)'phage and PL promoter. For the vector, any of pUC19, pUC18, pBR322, pHSG299, pHSG298, pHSG399, pHSG398, RSF1010, pMW119, pMW118, pMW219, and pMW218 may be used. Moreover, the vector of the phage DNA may be used. Further, an expression vector containing the promoter and capable of inducing the expression of inserted DNA sequences may be used.
To produce the peptide-synthesizing enzyme as a fused protein inclusion body, the gene encoding any other protein, preferably hydrophilic peptides is ligated to the upstream or downstream of the gene for the peptide-synthesizing enzyme. For the gene encoding aforementioned other proteins, any of genes, which have the ability to increase the accumulation level of fused proteins and enhance the solubility of denaturalized and reproduced proteins, may be used. The candidate for such genes include, for example, T7gene 10, β-galactosidase gene, dehydrofolate reductase gene, interferony gene, interleukin2 gene, and prochymosin gene.
To ligate any of these genes to the gene encoding the peptide-synthesizing enzyme, the reading frames of codons need to be aligned. To achieve it, these genes may be ligated at an appropriate site of restriction enzyme, or a synthesize DNA consisting of appropriate nucleotide sequences may be used.
In some cases, a terminator, namely a transcription termination sequence, is preferably linked to the downstream of the fused protein gene to increase the yield of proteins. Such terminators include, for example, T7 terminator, fd phage terminator, T4 terminator, tetracycline-resistant gene terminator and Escherichia coli trpA gene terminator.
It is preferable that the vector, which may be used in introducing into Escherichia coli the protein having the peptide-synthesizing activity or the gene encoding the fused protein consisting of the proteins having the peptide-synthesizing activity fused with other protein, is the so-called multi-copy type of vector and includes ColE1-derived plasmids having the replication origin, for example, pUC and pBR322 line plasmids or their derivatives. Herein, the term “derivatives” mean the plasmids modified by substitution, deletion, insertion, addition and/or invertion of the nucleotides. Note that herein, “modified” includes modification by the mutation techniques with a mutagenic agent or UV irradiation, or through the natural mutation process.
Furthermore, to select out the transformant, the vector preferably have the marker for, for example, the ampicillin-resistant gene. Expression vectors having the powerful promoters as these plasmids, are commercially available (pUC line (supplied from TaKaRa), pPROK line (supplied from Clontech), pKK233-2 (supplied from Clontech) and others).
The recombinant DNA may be obtained by ligating the DNA fraction formed through the linkage of the promoter, the gene encoding the protein having the peptide-synthesizing activity or the fused protein consisting of the protein having the peptide-synthesizing activity and other protein, and in some cases, a terminator to a vector DNA in that order.
Using the resulting recombinant DNA, transformation of, e.g., Escherichia coli may be performed. Cultivation of this Escherichia coli may result in expression and production of the peptide-synthesizing enzyme or the fusion protein of the peptide-synthesizing enzyme and the other protein. The host to be transformed may be strains that are usually employed for the expression of foreign genes. Preferable examples thereof may include Escherichia coli JM109 strain, a subspecies of Escherichia coli K12. Methods for performing transformation and methods of selecting the transformant are described in Molecular Cloning, 2nd edition, Cold Spring Harbor Press (1989) and the like.
In the case of expressing the enzyme as a part of the fusion protein, the fusion protein may be composed so as to be able to cleave the peptide-synthesizing enzyme therefrom using a restriction enzyme which recognizes a sequence of blood coagulation factor Xa, kallikrein or the like which is not present in the peptide-synthesizing enzyme.
The production media to be used may include the media usually used for culturing Escherichia coli, such as M9-casamino acid medium and LB medium. Culture conditions and production induction conditions may be appropriately selected depending on types of the vector marker, the promoter, the host bacterium and the like.
The peptide-synthesizing enzyme or the fusion protein of the peptide-synthesizing enzyme and the other protein may be recovered by the following method: when the peptide-synthesizing enzyme or the fusion protein of the peptide-synthesizing enzyme is solubilized in the microbial cells, the microbial cells may be recovered and then disrupted or lysed, to obtain a crude enzyme solution. If necessary, the peptide-synthesizing enzyme or the fusion protein may further be subjected to purification in accordance with ordinary methods such as precipitation, filtration and column chromatography. The purification may also be performed in accordance with methods utilizing an antibody against the peptide-synthesizing enzyme or the fusion protein.
In the case where the protein inclusion body is formed, this may be solubilized with a denaturing agent. The inclusion body may be solubilized together with the microbial cells. However, considering the following purification process, it is preferable to remove the inclusion body before solubilization. Collection of the inclusion body from the microbial cells may be performed in accordance with conventionally and publicly known methods. For example, the microbial cells are disrupted, and the inclusion body is recovered by centrifugation and the like. The denaturing agent which solubilizes the protein inclusion body may include guanidine-hydrochloric acid (e.g., 6 M, pH 5 to 8), urea (e.g., 8 M), and the like.
As a result of removal of the denaturing agent by dialysis and the like, the protein may be regenerated as having the activity. Dialysis solutions used for the dialysis may include tris hydrochloric acid buffer, phosphate buffer and the like. The concentration thereof may be 20 mM to 0.5 M, and pH thereof may be 5 to 8.
It is preferred to keep that the protein concentration at a regeneration step is kept at about 500 μg/ml or less. In order to inhibit self-crosslinking of the regenerated peptide-synthesizing enzyme, it is preferred that dialysis temperature is kept at 5° C. or below. Methods for removing the denaturing agent other than the dialysis method may include a dilution method and an ultrafiltration method. The regeneration of the activity is anticipated by using any of these methods.
By transforming the microorganism, of which pepD, pepA, iadA, or pepE gene has been disrupted in the aforementioned manner, the microorganism with the increased expression of amino-acid ester transpeptidase and the reduced or lost activity of decomposing alanylglutamine and aspartylphenylalanine may be produced.
The method for producing the peptides of the present invention involves forming the peptides using the aforementioned microorganisms of the present invention. Namely, the method for producing the peptides of the present invention involves the step for cultivating the microorganism, of which at least one gene on the chromosome selected from the group consisting of genes encoding aminoacylhistidine peptidase, luecylaminopeptidase, and isoaspartyldipeptidase has been disrupted and which has been transformed with a recombinant DNA containing the polynucleotide encoding the proteins having the peptide-synthesizing activity, in the medium, followed by mixing at least one of the cultivated microorganisms and the disrupted cells thereof with carboxy and amine components to synthesize peptides. According to further another preferable mode, for the aforementioned microorganism, the microorganism, of which gene encoding α-aspartyldipeptidase on the chromosome has been further disrupted.
For the microorganism used in the present invention to act on the carboxy and amine components, the aforementioned microorganisms or the disrupted cells of the microorganisms may be mixed with these components. More specifically, the microorganism may be added into the solution containing carboxy and amine components to induce the reaction. Alternatively, such a method may be used that the microorganism having the ability to form the target peptides is cultivated, the enzyme is formed and accumulated in the microorganisms or the culture fluid of the microorganism, and the carboxy and amine components are added into them. The formed peptides may be recovered in the usual manner and purified if necessary.
Herein, the term “disrupted cells of microorganisms” refers to a mixture containing the contents of a cell obtained by disrupting the cell membrane of the microorganism. It includes not only the contents of the cell obtained by physically disrupting the cell membrane but also that obtained by chemically dissolving the cell membrane.
The microorganism of the present invention, in which the specific gene has been disrupted, is used. In producing the peptides, not only the microorganism cells, but also the treated microorganism cell products such as acetone-treated microorganism cells or freeze-dried microorganism cells may be used as the microorganism. Alternatively, the microorganism cells or the treated microorganism cell products immobilized by any of the covalent binding method, the absorption method, the entrapment method, and so forth may be used. Note that in many cases, there is an enzyme dissolving the formed peptides rather than involving in peptide formation. In such a case, any of metal-protease inhibitors such as ethylenediamine tetraacetic acid (EDTA) may be preferably added. The quantity of added inhibitor is 0.1 mM to 300 mM, and preferably ranges from 1 mM to 100 mM.
As the carboxy component, any of substrates capable of condensing with the amine component, another substrate, to form peptides may be used. The carboxy component includes, for example, L-amino-acid ester, D-amino-acid ester, L-amino-acid amide, D-amino-acid amide, and organic-acid ester with no amino group. The examples of amino-acid esters include not only amino acid ester corresponding to natural amino acid but also that corresponding to non-natural amino acid or to its derivatives. Further, the examples of amino-acid esters include not only α-amino-acid ester but also β-, γ-, and ω-amino-acid esters, which have different amino group binding sites. The typical examples of amino-acid esters may include, for example, methyl ester, ethyl ester, n-propyl ester, isopropyl ester, n-butyl ester, isobutyl ester, and tert-butyl ester of amino acids.
As the amine component, any of substrates capable of condensing with the carboxy component, another substrate, to form the peptides may be used. The amine component includes, for example, L-amino acid, C-protected L-amino acid, D-amino acid, C-protected D-amino acid, and amine. Further, the examples of amines include not only natural amine but also non-natural amine or its derivatives. Furthermore, the examples of amino acids include natural amino acid but also non-natural amino acid or its derivatives. Furthermore, the examples of amino acids include not only α-amino acid but also β-, γ-, and ω-amino acid, which have different amino group binding sites.
The concentrations of carboxy and amine components, starting materials, are 1 mM to 10 M, respectively, and preferably 0.05 M to 2M, respectively, In some cases, however, more than equal amount of amine component may be preferably added compared with the carboxy component. If the high-concentration of substrates inhibits the reaction, the substrates may be added bit by bit at concentrations, which do not inhibit the reaction.
The peptides may be synthesized at the reaction temperature ranging from 0 to 60° C., and preferably 5 to 40° C. The peptides may be synthesized at the reaction pH value ranging from pH 6.5 to 10.5 and preferably, pH7.0 to 10.0.
The examples for carrying out the present invention are explained below. However, the present invention is not limited to the following examples for carrying out the present invention.
In the process mentioned below, the Escherichia coli ATCC8739 strain was used as a parent strain. Aminoacylhistidine dipeptidase gene (pepD gene), isoaspartyldipeptidase gene (iadA gene), α-aspartyldipeptidase gene (pepE gene), leucylaminopeptidase gene (pepA gene) of the parent strain were disrupted in that order to construct the pepD-deficient strain, the pepD-iadA double deficient strain, the pepD-iadA-pepE triple deficient strain, and the pepD-iadA-pepE-pepA quadruple deficient strain, and aspartylphenylalanine decomposition activity of them were determined.
(1) Disruption of Aminoacylhistidine Dipeptidase Gene (pepD Gene)
Based on sequence information on aminoacylhistidine dipeptidase gene (pepD gene) (DDBJ/EMBL/GeneBank Accession No. AE000132) in Gene Data Bank, the primers of 5′-GATCTGGCGCACTAAAAACC (SEQ ID NO: 1) and 5′-GGGATGGCTTTTATCGAAGG (SEQ ID NO: 2) were synthesized. The primers were used to amplify approximately 1.6 Kbp of structural gene, which covered SD-ATG and a translation termination codon by the PCR method (94° C., 1 min, 54° C., 2 min, 72° C., 3 min, 30 cycles) using a genome DNA of the Escherichia coli ATCC8739 strain as a template. Using SureClone Ligation Kit (supplied from Amersham Pharmacia Biotech), the amplified structural gene was ligated to the Sma I site of a pUC18 (supplied from TaKaRa) vector to form a pUC18-pepD gene. The Escherichia coli JM109 competent cells (supplied from TaKaRa) were transformed with the plasmid and grown on the LB agar plate(Tryptone 1%, Yeast extract 0.5%, NaCl 0.5%, agar 1.5%, pH7.0) containing 50 μg/ml of ampicillin. The transformant was cultivated in the LB liquid medium (Tryptone 1%, Yeast extract 0.5%, NaCl 0.5%, pH7.0) containing 50 μg/ml of ampicillin at 37° C. for 16 hours to prepare the plasmid from recovered transformant. Then, pUC18-pepD was cleaved at Nru I and Hpa I sites (the restriction enzyme sites in 1.6 Kbp of the inserted fragment containing the pepD gene) and self-ligation reaction was induced. Using the ligation reaction mixture, the competent cells of the Escherichia coli JM109 strain were transformed and the plasmid was prepared from the transformant growing on the LB agar plate containing 50 μg/ml of ampicillin. From resultant products, the plasmid DNA, pUCΔpepD having 1.4 Kbp of the inserted DNA fragment, was selected. It is expected that the pepD gene ligated to the plasmid might lose the Nru I-Hpa I region and the enzyme to be encoded has been inactivated.
Then, pUCΔpepD was cleaved at the EcoR I and Sal I sites to prepare 1.4 Kbp of DNA fragment containing the deficient pepD gene. The DNA fragment was ligated to the EcoR I/Sal I sites of pMAN997 having the temperature-sensitive replication origin (tsori), the vector for homologous replacement, to form the plasmid for deficient pMANΔpepD gene. The Escherichia coli JM 109 strain, a subspecies of the Escherichia coli K12 strain transformed with pMANΔpepD, was cultivated in the LB liquid medium containing 50 μg/ml of ampicillin at 30° C. for 16 hours to prepare pMANΔpepD from the recovered transformant.
Then, using the plasmid pMANΔpepD for the deficient pepD gene, the Escherichia coif ATCC8739 strain was transformed by electroporation and grown in the LB agar plate containing 50 μg/ml of ampicillin at 30° C. (Note that among the aforementioned strains, those with ATCC numbers have been deposited in American Type Culture Collection (P.O. Box 1549 Manassas, Va. 20110, the United States of America) and may be furnished by referring to the respective numbers.) A plurality of obtained transformants were cultivated in 4 ml of LB medium containing 50 μg/ml of ampicillin (in a φ1.4 cm×18 cm test tube) at 30° C. for 16 hours. The culture solution was diluted with physiological saline, applied into the LB agar plate containing 50 μg/ml of ampicillin, and cultivated at 42° C. for 10 hours to obtain a single colony. Further, the obtained single colony was cultivated again in the same manner as the aforementioned one to isolate the single colony, and a clone with the entire plasmid integrated in the chromosome by homologous replacement was selected. Furthermore, the plasmid was extracted from the homologous recombinant strain cultivated in the LB medium containing 50 μg/ml of ampicillin and it was verified that the strain had no plasmid in the cytoplasmic solution.
Then, 10 clones were selected from those with the entire plasmids incorporated in the chromosomes by homologous replacement in the aforementioned manner and cultivated in the M9 minimum liquid medium (4 ml, Na2PO4 6.8 g, KH2PO4 3 g, NaCl 0.5 g, NH4Cl 1 g, MgSO4.7H2O 0.5 g, CaCl2.2H2O 15 mg, ThiaminHCl 2 mg, and Glucose 0.2 g/mL, pH7.0) at 30° C. for 24 hours. 100 μl of the culture solution was applied into the same medium (4 ml) and further cultivated at 42° C. for 24 hours. The culture solution was diluted with physiological saline, spread on the M9 minimum plate, cultured at 42° C. for 12 hours to obtain a single colony. The obtained colony was applied to the LB agar plate and the LB agar plate containing 50 μg/ml of ampicillin, and cultivated at 30° C. for 12 hours. After the recombination process was repeated twice, the strain, which acquired the sensitivity to ampicillin and grown only on the LB agar gel, was selected from the resultant products. Using the chromosome DNA of the obtained strain, in which recombination was repeated twice, as template and the primers having the nucleotide sequences in SEQ.NOs.1 and 2, the pepD fragment was amplified by PCR. It was confirmed that the amplified pepD gene was the pepD gene fragment (approximately 1.4 Kbp) with the Nru I-Hpa I site deleted and the pepD gene of the strain was replaced by the deficient pepD gene. Therefore, the selected strain was verified to be the pepD deficient strain.
(2) Obtaining Isoaspartyldipeptidase Gene (iadA Gene) Deficient Strain
Based on sequence information (DDBJ/EMBL/GeneBank Accession No. AE000503) on isoaspartyldipeptidase gene (iadA gene) in Gene Data Bank, the primers (5′-CAAGGAGTTACCATGATTGA (SEQ ID NO: 3) and 5′-AACCGTTTAAGCCGTTTCAA (SEQ ID NO: 4)) were synthesized. The primers were used to amplify approximately 1.7 Kbp of the structural gene, which covered SD-ATG and the translation termination codon, by PCR (94° C., 1 min, 54° C., 2 min, 72° C., 3 min, 30 cycles) with the genome DNA of the Escherichia coli ATCC8739 strain as template. The gene was ligated to the Sma I site of the pUC18 vector using SureClone Ligation Kit to form pUC18-iadA. The competent cells of the Escherichia coli JM109 strain transformed with the plasmid were cultivated in the liquid medium containing 50 μg/ml of ampicillin at 37° C. for 16 hours and the plasmid was prepared from the recovered transformant. Then, pUC18-iadA was cleaved at the Hpa I site (the restriction enzyme site in 1.7 Kbp of the inserted fragment containing the idaA gene) and ligated to an EcoR I-Not 1-BamH I adapter (supplied from TaKaRa). The plasmid was further cleaved at the Not I site to induce the self-ligation reaction. Using the ligation reaction mixture, the competent cells of the Escherichia coli JM109 strain were transformed and the plasmid was prepared from the transformant grown in the LB agar plate containing 50 μg/ml of ampicillin. From the resultant products, the plasmid DNA, pUCΔiadA cleaved at the Not I site, was selected. It is expected that in the iadA gene contained in the pladmid DNA, frame shift occurs at the Hpa I site and the enzyme to be encoded has been inactivated.
Then, pUCΔiadA was cleaved at the EcoR I and Sal I sites, 1.7 Kbp of DNA fragment containing the deficient iadA gene was prepared and ligated to the EcoR I/Sal I site of pMAN997, the vector for homologous replacement having the temperature-sensitivity replication origin (tsori) to construct the plasmid for the deficient iadA gene, pMANΔiadA. The Escherichia coli JM 109 strain transformed with pMANΔiadA was cultivated in the LB liquid medium containing 50 μg/ml of ampicillin at 30° C. for 16 hours and pMANΔiadA was prepared from the recovered transformant. Using the plasmid for the deficient iadA gene, the pepD deficient strain of the aforementioned Escherichia coli ATCC8739 was transformed by electroporation. Subsequently, in the same manner, the iadA gene was replaced by the deficient iadA gene to obtain the strain, in which recombination was repeated twice and which has acquired the sensitivity to ampicillin. Using the chromosome DNA of the strain, in which recombination was repeated twice, as the template and the primers for the sequences categorized in SEQ.NOs. 3 and 4 the iadA fragment was amplified by PCR. It was confirmed that the amplified iadA fragment was cleaved at the restriction enzyme Not I site and the iadA gene of the strain was replaced by the deficient iadA gene. The obtained strain was verified to be a pepD-iadA double deficient strain.
(3) Obtaining α-Aspartyldipeptidase Gene (pepE Gene) Deficient Strain
Based on sequence information (DDBJ/EMBL/GeneBank Accession No. AE000475) on α-aspartyldipeptidase gene (pepE gene) in Gene Data Bank, the primers (5′-TATTTGTTATTT CCATTGGC (SEQ ID NO: 5) and 5′-AATGTCGCTCAACCTTGAAC (SEQ ID NO: 6)) were synthesized. The primers were used to amplify approximately 1.4 Kbp of structural gene, which covered SD-ATG and the translation termination codon, by the PCR (94° C., 1 min, 54° C., 2 min, 72° C., 3 min, 30 cycles) using of the genome DNA of the Escherichia coli ATCC8739 strain as template. The gene was ligated to the Sma I site of the pUC18 vector using SureClone Ligation Kit to construct pUC18-pepE. The competent cells of the Escherichia coli JM109 strain transformed with the plasmid was cultivated in the liquid medium containing 50 μg/ml of ampicillin at 37° C. for 16 hours and the plasmid was prepared from the recovered transformant. Then, pUC18-pepE was cleaved at the Nru I site (the restriction enzyme site in 1.4 Kbp of inserted fragment containing the pepE fragment) and ligated to the EcoR I-Not I-BamH I adapter. The plasmid was further cleaved at the Not I site to induce the self-ligation reaction. Using the ligation reaction mixture, the Escherichia coli JM109 competence cells were transformed and the plasmid was prepared from the transformant grown in the LB agar plate containing 50 μg/ml of ampicillin. From the resultant products, the plasmid DNA, pUCΔpepE to be separated at the Not I site was selected. It is expected that in the pepE gene contained in the plasmid DNA, frame sift occurs and the enzyme to be encoded has been inactivated.
Then, pUCΔpepE was separated at the EcoR I and Sal I sites and 1.4 Kbp of DNA fragment containing the deficient pepE gene was prepared. The DNA fragment was ligated to the EcoR I/Sal I site of pMAN997, the vector for homologous replacement having the temperature sensitivity replication origin (tsori) to construct the plasmid pMANΔpepE for the deficient pepE gene. The Escherichia coli JM 109 strain transformed with pMANΔpepE was cultivated in the LB liquid medium containing 50 μg/ml of ampicillin at 30° C. for 16 hours and pMANΔpepE was prepared from the recovered transformant. Using the plasmid for the deficient pepE gene, the pepD-iadA double deficient strain of the aforementioned Escherichia coli ATCC8739 by electroporation was transformed. Subsequently, in the same manner, the pepE gene was replaced by the deficient pepE gene to obtain the strain having the sensitivity to ampicillin, in which recombination was repeated twice. Using the chromosome DNA of the strain, in which recombination was repeated twice, as the template and the primers having the sequences in SEQ.NOs.5 and 6, the pepE fragment was amplified by PCR. It was confirmed that the amplified pepE fragment was separated at the restriction enzyme Not I site and the pepE gene of the strain was replaced by the deficient pepE gene. The strain was verified to be the pepD-iadA-pepE triple deficient strain.
(4) Obtaining the Aminopeptidase Gene (pepA Gene) Deficient Strain
Based on sequence information (DDBJ/EMBL/GeneBank Accession No. AE000496) on the amino peptidase gene (pepA gene) in Gene Data Bank, the primers (5′-ACAGCGGACATGAGTTACGA (SEQ ID NO: 7) and 5′-CCCGCTAAATTATGCGGAAC (SEQ ID NO: 8)) were synthesized. The primers were used to amplify approximately 1.9 Kbp of structural gene, which covered SD-ATG and the translation termination codon by the PCR method (94° C., 1 min, 54° C., 2 min, 72° C., 3 min, 30 cycles) using the genome DNA of the Escherichia coli ATCC8739 strain as template. The gene was ligated to the Sma I site of the pUC18 vector using SureClone Ligation Kit to construct pUC18-pepA. The competent cells of the Escherichia coli JM109 strain transformed with the plasmid was cultivated in the liquid medium containing 50 μg/ml of ampicillin at 37° C. for 16 hours and the plasmid was prepared from the recovered transformant. Then, pUC18-pepA was cleaved at the Hpa I site (the restriction enzyme site in 1.9 Kbp of inserted fragment containing the pepA fragment) to induce the self-ligation reaction. Using the ligation reaction mixture, the competent cells of the Escherichia coli JM109 strain were transformed and the plasmid was prepared from the transformant grown in the LB agar plate containing 50 μg/ml of ampicillin. From the plasmid, the plasmid DNA, pUCΔpepA to be cleaved at the Hpa I site was selected. It is expected that in pepA contained in the plasmid DNA, the Hpa I-Hpa I region was lost and the enzyme to be encoded has been inactivated. Then, pUCΔpepA was cleaved at the Sac I and Sph I sites and 1.9 Kbp of DNA fragment containing the deficient pepE gene was prepared. The DNA fragment was ligated to the Sac I/Sph I site of pMAN997, the vector for homologous replacement having the temperature sensitivity replication origin (tsori) to construct the plasmid pMANΔpepA for the deficient pepA gene. The Escherichia coli JM 109 strain transformed with pMANΔpepA was cultivated in the LB liquid medium containing 50 μg/ml of ampicillin and pMANΔpepA was prepared from the recovered transformant. Using the plasmid for the deficient pepA gene, the aforementioned triple deficient Escherichia coli ATCC8739 strain with the pepD, iadA, and pepE genes deleted was transformed by electroporation. Subsequently, in the same manner, the pepA gene was replaced by the deficient pepA gene to obtain the strain having the sensitivity to ampicillin, in which recombination was repeated twice. Using the chromosome DNA of the strain, in which recombination was repeated twice, as the template and the primers having the sequences in SEQ.NOs. 7 and 8, the pepA fragment was amplified by PCR. It was confirmed that since the amplified pepA fragment was cleaved at the restriction enzyme Mul I site and 849 bp and 1039 bp of DNA fragments were formed, the pepA gene of the strain was replaced by the deficient pepA gene. The strain was verified to be the pepD-iadA-pepE-pepA quadruple deficient strain.
The parent strain and each of gene deficient strains were applied in 4 ml of LB medium and shake-cultured at 30° C. for 16 hours. Then, 4 ml of culture solution was centrifuged (2200×g 15 min) to obtain microorganism cell precipitates. 4 ml of physiological saline was added to the microorganism cell precipitates and centrifuged (2200×g 15 min) to obtain the washed microorganism cells. The washed microorganism cells were suspended in 1 ml of ultrasonic homogenated solution (20 mM MOPS-KOH buffer (pH7.0) containing 1 mM of DTT). The suspension was subject to the ultrasonic disruption (with the apparatus supplied from Bioruptor, 7.5 min) and centrifuged (12000×g 10 min) to obtain a cell-free extracted solution. Using the protein assay CBB solution (supplied from Nakarai Tesk), the proteins were quantified by the Bradford method. Bovine serum albumin (supplied from SIGMA) was used as the standard protein.
100 μl of cell-free extracted solution was added in 100 μl of substrate solution (100 mM of aspartylphenylalanine, 2 mM of MnCl2, 100 mM of MOPS-KOH buffer (pH7.0)) and the reaction was performed at 30° C. for 2 hours. After the reaction, the reaction mixture was heated at 95° C. for 5 minutes, and 5-fold diluted with distilled water. 10 μl of diluted reaction mixture was analyzed using an amino acid analyzer (L-8500, supplied from Hitachi) and produced aspartic acid and phenylalanine were quantified.
Aspartylphenylalanine decomposition activities in the parent strain and each of gene deficient strains are shown in Table 1. Note that the amount of enzyme, which forms 1 μmol of Phe/minute at 30° C., was defined as one unit. In the parent strain, the strong aspartylphenylalanine decomposition activity was observed, while it reduced as each of genes was stepwise deleted. In the quadruple deficient strain with the pepD, iadA, pepE, and pepA genes deleted, the decomposition activity decreased down to approximately 1.6% of that of the parent strain.
Escherichia coli
The parent strain and each of gene deficient strains were applied in 3 ml of LB medium (Bacto tryptone 1.0%, Bacto yeast extract 1.0%, NaCl 1.0%, PH7.0) and shake-cultured at 37° C. for 16 hours. Then, 1 ml of culture solution was centrifuged (2200×g 15 min) to obtain the microorganism cell precipitates. 1 ml of physiological saline was added to the microorganism cell precipitates, and then centrifugation was performed (2200×g 15 min) to obtain the washed microorganism cells. 0.1 ml of substrate solution (100 mM alanylglutamine, 100 mM boric acid-NaOH buffer (pH9.0)) was added to the washed microorganism cells, and the reaction was performed at 30° C. for 6 hours.
Alanylglutamine in the reaction mixture was quantified by HPLC under the conditions described below to find the quantity of discomposed alanylglutamine. Column:Inertsil ODS-2 (4.6×250 mm, supplied from GL science), mobilizing layer: 5 mM sodium 1-octanesulfonate:Methanol=10:1.5 (pH 2.1 with conc.H3PO4), flow rate of 1.0 ml/min, temperature of 40° C., detection at UV210 nm.
The alanylglutamine decomposition activities in the parent strain and each of gene deficient strains are shown in the table below. In the parent strain, after the 6-hour reaction, 100 mM of alanylglutamine was completely decomposed while in the pepD deficient strain, alanylglutamine decomposition activity significantly reduced. When the pepE and pepA genes were deleted, alanylglutamine decomposition activity further reduced.
Escherichia coli JM 109
Hereinafter, isolation of a gene for peptide-synthesizing enzyme will be explained. Empedobacter brevis strain FERM BP-8113 was used as the microbe. For isolating the gene, Escherichia coli JM-109 was used as a host while pUC118 was used as a vector.
(1) Construction of PCR Primer Based on Determined Internal Amino Acid Sequence
A mixed primer having the nucleotide sequences indicated in SEQ ID NO: 11 and SEQ ID NO: 12, respectively, was constructed based on the amino acid sequences (SEQ ID NO: 9 and 10) determined by the Edman's decomposition method detecting the digestion product of lysyl endopeptidase of a peptide-synthesizing enzyme derived from the Empedobacter brevis strain FERM BP-8113.
(2) Preparation of Microbial Cells
Empedobacter brevis strain FERM BP-8113 was cultivated at 30° C. for 24 hours on a CM2G agar medium (containing glucose 5 WI, yeast extract 10 g/l, peptone 10 g/l, sodium chloride 5 g/l, and agar 20 g/l, pH 7.0). One loopful cells of the resulting microbial cells was inoculated into a 500 ml Sakaguchi flask containing 50 ml of a CM2G liquid medium (the aforementioned medium excluding agar) followed by shake culture at 30° C.
(3) Preparation of Chromosomal DNA from Microbial Cells
50 ml of culture solution was centrifuged (12,000 rpm, 4° C., 15 minutes) to recover the microbial cells. Then, a chromosomal DNA was obtained from the microbial cells using the QIAGEN Genomic-Tip System (supplied from Qiagen) based on the procedure described in the manual therefor.
(4) Preparation of DNA Fragment Containing Part of Gene for Peptide-Synthesizing Enzyme by PCR
A DNA fragment containing a portion of the gene for the peptide-synthesizing enzyme derived from Empedobacter brevis strain FERM BP-8113 was obtained by the PCR method using LA-Taq (supplied from Takara Shuzo). A PCR reaction was then carried out by using the primers having the nucleotide sequences of SEQ ID NOs: 11 and 12 to a chromosomal DNA obtained from Empedobacter brevis strain FERM BP-8113.
The PCR reaction was carried out for 30 cycles under the following conditions using the Takara PCR Thermal Cycler PERSONAL (supplied from Takara Shuzo).
After completion of the reaction, 3 μl of the racrion mixture was applied to 0.8% agarose electrophoresis. As a result, it was verified that a DNA fragment of about 1.5 kilobases (kb) was amplified.
(5) Cloning of Gene for Peptide-Synthesizing Enzyme from Gene Library
In order to obtain the entire length of gene for peptide-synthesizing enzyme in full-length, southern hybridization was carried out by using the DNA fragment amplified in the PCR procedure as a probe. The procedure for southern hybridization is explained in Molecular Cloning, 2nd edition, Cold Spring Harbor Press (1989).
The approximately 1.5 kb DNA fragment amplified by the PCR procedure was separated by 0.8% agarose electrophoresis. The target band was then cut out and purified. The DNA fragment was labeled with digoxinigen as probe by using DIG High Prime (supplied from Boehringer-Mannheim) based on the procedure described in the manual therefor using DIG High Prime (supplied from Boehringer-Mannheim).
After completely digesting the chromosomal DNA of Empedobacter brevis obtained in the step (3) of the present Reference 1 by reacting at 37° C. for 16 hours with restriction enzyme HindIII, the resultant was electrophoresed with on 0.8% agarose gel. The electrophoresed chromosomal DNA was blotted onto a positively charged Nylon membrane filter (supplied from Roche Diagnostics) from the agarose gel after the electrophoresis, followed by treatments consisting of alkaline denaturation, neutralization and immobilization. Hybridization was carried out by using EASY HYB (supplied from Boehringer-Mannheim). After pre-hybridizing the filter at 50° C. for 1 hour, the probe labeled with digoxinigen prepared as described above was added and hybridization was carried out at 50° C. for 16 hours. Subsequently, the filter was washed for 20 minutes at room temperature with 2×SSC containing 0.1% SDS. Moreover, the filter was additionally washed twice at 65° C. for 15 minutes with 0.1×SSC containing 0.1% SDS.
Detection of bands that hybridized with the probe was carried out by using the DIG Nucleotide Detection Kit (supplied from Boehringer-Mannheim) based on the procedure described in the manual therefor using the DIG Nucleotide Detection Kit (supplied from Boehringer-Mannheim). As a result, a roughly 4 kb band was able to be detected that hybridized with the probe.
Then, 5 μg of the chromosomal DNA prepared in the step (3) of the present Reference 1 was completely digested with HindIII. A roughly 4 kb of DNA was separated by 0.8% agarose gel electrophoresis, followed by purification of the DNA using the Gene Clean II Kit (supplied from Funakoshi) and dissolving the DNA in 10 μl of TE. 4 μl of this product was then mixed with pUC118 HindIII/BAP (supplied from Takara Shuzo) and a ligation reaction was carried out by using the DNA Ligation Kit Ver. 2 (supplied from Takara Shuzo). 5 μl of the ligation reaction mixture and 100 μl of competent cells of Escherichia coli JM109 (supplied from Toyobo) were mixed to transform the Escherichia coli. This was then applied to a suitable solid medium to construct a chromosomal DNA library.
To obtain the full-length of gene for peptide-synthesizing enzyme, the chromosomal DNA library was screened by colony hybridization using the aforementioned probe. The procedure for colony hybridization is explained in Molecular Cloning, 2nd edition, Cold Spring Harbor Press (1989).
The colonies of the chromosomal DNA library were transferred on a Nylon membrane filter (Nylon Membrane for Colony and Plaque Hybridization, (supplied from Roche Diagnostics) followed by treatments consisting of alkali denaturation, neutralization and immobilization. Hybridization was carried out using EASY HYB (supplied from Boehringer-Mannheim). After pre-hybridizing the filter at 37° C. for 1 hour, the aforementioned probe labeled with digoxinigen was added, followed by hybridization at 50° C. for 16 hours. In addition, the filter was washed for 20 minutes at room temperature with 2×SSC containing 0.1% SDS. Moreover, the filter was additionally washed twice at 65° C. for 15 minutes with 0.1×SSC containing 0.1% SDS.
Detection of colonies hybridizing with the labeled probe was carried out by using the DIG Nucleotide Detection Kit (supplied from Boehringer-Mannheim) based on the explanation described in the manual therefor using the DIG Nucleotide Detection Kit (supplied from Boehringer-Mannheim). As a result, two strains of colonies were verified to hybridize with the labeled probe.
(6) Nucleotide Sequence of Gene for Peptide-Synthesizing Enzyme Derived from Empedobacter brevis
Plasmids possessed by Escherichia coli JM109 were prepared from the aforementioned two strains of microbial cells that were verified to hybridize with the labeled probe by using the Wizard Plus Minipreps DNA Purification System (supplied from Promega) to and the nucleotide sequence of a portion where hybridization with the probe occurred and nearby was determined. The sequencing reaction was carried out by using the CEQ DTCS-Quick Start Kit (supplied from Beckman-Coulter) based on the procedure described in the manual therefor. In addition, electrophoresis was carried out by using the CEQ 2000-XL (supplied from Beckman-Coulter).
As a result, it was verified that an open reading frame that encodes a protein containing the internal amino acid sequences of the peptide-synthesizing enzyme (SEQ ID NOs: 9 and 10) did exist, thereby confirming that the open reading frame was a gene encoding the peptide-synthesizing enzyme. The nucleotide sequence of the full-length of the gene for peptide-synthesizing enzyme along with the corresponding amino acid sequence is shown in SEQ ID NO: 13. As a result of analysis on the homology of the resulting open reading frame with the BLASTP program, homology was discovered between the two enzymes; it showed with a homology of 34% as at the amino acid sequence level exhibited with the α-amino acid ester hydrolase of Acetobacter pasteurianus (see Appl. Environ. Microbiol., 68(1), 211-218 (2002), and a homology of 26% at the amino acid sequence level exhibited with the glutaryl-7ACA acylase of Brevibacillus laterosporum (see J. Bacteriol., 173(24), 7848-7855 (1991).
(7) Expression of Gene for Peptide-Synthesizing Enzyme Derived From Empedobacter brevis in Escherichia coli
The promoter region of the trp operon on the chromosomal DNA of Escherichia coli W3110 was amplified by PCR using the oligonucleotides indicated in SEQ ID NOs: 15 and 16 as primers, and the resulting DNA fragments were ligated to a pGEM-Teasy vector (supplied from Promega). E. coli JM109 was then transformed with this ligation solution, and those strains having the target plasmid in which the direction of the inserted trp promoter is inserted in the opposite to the orientation from of the lac promoter were selected from ampicillin-resistant strains.
Next, a DNA fragment containing the trp promoter obtained by treating this plasmid with EcoO109I/EcoR I was ligated to an EcoO109I/EcoR I treatment product of pUC19 (supplied from Takara). Escherichia coli JM109 was then transformed with this ligation solution and those strains having the target plasmid were selected from ampicillin-resistant strains. Next, a DNA fragment obtained by treating this plasmid with HindIII/PvuII was ligated with to a DNA fragment containing an rrnB terminator obtained by treating pKK223-3 (supplied from Amersham Pharmacia) with HindIII/HincII. E. coli JM109 was then transformed with this ligation solution, strains having the target plasmid were selected from ampicillin-resistant strains, and the plasmid was designated as pTrpT.
The target gene was amplified by PCR using the chromosomal DNA of Empedobacter brevis strain FERM BP-8113 as a template and the oligonucleotides indicated in SEQ ID NO: 17 and 18 as primers. This DNA fragment was then treated with NdeI/PstI, and the resulting DNA fragment was ligated with the NdeI/PstI treatment product of pTrpT. Escherichia coli JM109 was then transformed with this ligation solution, those strains having the target plasmid were selected from ampicillin-resistant strains, and this plasmid was designated as pTrpT_Gtg2.
Escherichia coli JM109 having pTrpT_Gtg2 was pre-cultured at 30° C. for 24 hours in LB medium containing 100 mg/l of ampicillin. 1 ml of the resulting culture solution was transferred in a 500 ml Sakaguchi flask containing 50 ml of a medium (D-glucose 2 g/l, yeast extract 10 WI, casamino acids 10 g/l, ammonium sulfate 5 g/l, potassium dihydrogen phosphate 3 g/l, dipotassium hydrogen phosphate 1 WI, magnesium sulfate heptahydrate 0.5 WI, and ampicillin 100 mg/l), followed by cultivation at 25° C. for 24 hours. The culture solution had an α-L-aspartyl-phenylalanine-β-methyl ester forming activity of 0.11 Upper 1 ml of culture solution and it was verified that the cloned gene was expressed by E. coli. Furthermore, no activity was detected for a transformant in which only pTrpT had been introduced as a control.
When the amino acid sequence of SEQ ID NO: 6 described in the Sequence Listing was analyzed with the Signal P v 1.1 program (see Protein Engineering, Vol. 12, No. 1, pp. 3-9, 1999), it was predicted that amino acids numbers 1 to 22 in amino acid sequence was operated as a signal that is secreted into the periplasm, while the mature protein was estimated to be downstream of amino acid number 23.
Escherichia coli JM109, having pTrpT_Gtg2, was pre-cultivated at 30° C. for 24 hours in LB medium containing 100 mg/l of ampicillin. 1 ml of the resulting culture solution was transferred into a 500 ml Sakaguchi flask containing 50 ml of medium (glucose 2 WI, yeast extract 10 g/l, casamino acids 10 g/l, ammonium sulfate 5 WI, potassium dihydrogen phosphate 3 g/l, dipotassium hydrogen phosphate 1 g/l, magnesium sulfate heptahydrate 0.5 g/l, and ampicillin 100 mg/l), followed by mass-cultivation at 25° C. for 24 hours to obtain cultivated microbial cells.
The cultivated microbial cells were fractionated into a periplasm fraction and a cytoplasm fraction by an osmotic pressure shock method using a 20 grams/deciliter (g/dl) sucrose solution. The microbial cells immersed in the 20 g/dl sucrose solution were immersed in a 5 mM aqueous MgSO4 solution. The centrifuged supernatant was named a periplasm fraction (“Pe”). In addition, the centrifuged sediment was re-suspended and subjected to ultrasonic disrupting. The resultant was named a cytoplasm fraction (“Cy”). The activity of glucose 6-phosphate dehydrogenase, which is known to be present in the cytoplasm, was used as an indicator to verify that the cytoplasm had been separated. This measurement was carried out by adding a suitable amount of enzyme to a reaction mixture at 30° C. containing 1 mM glucose 6-phosphate, 0.4 mM NADP, 10 mM MgSO4, and 50 mM Tris-Cl (pH 8), followed by measurement of absorbance at 340 nm to measure production of NADPH.
The amounts of enzymes of in the periplasm fraction and the cytoplasm fraction when the activity of a separately prepared cell-free extract was assigned a value of 100% are measured. Glucose 6-phosphate dehydrogenase activity did not be observed in the periplasm fraction. It indicates that the periplasm fraction did not mix in the cytoplasm fraction. About 60% of the α-L-aspartyl-L-phenylalanine-β-methyl ester (α-AMP) synthesizing activity was recovered in the periplasm fraction, and it was verified that the Ala-Gln-forming enzyme was secreted into the periplasm as predicted from the amino acid sequence using the Signal P v 1.1 program.
Hereinafter, isolation of a gene for peptide-synthesizing enzyme is described. The microbe used was Sphingobacterium sp. strain FERM BP-8124. For the isolation of the gene, Escherichia coli DH5α was used as a host, and pUC118 was used as a vector.
Sphingobacterium sp. strain FERM BP-8124 was cultivated for 24 hours at 25° C. on a CM2G agar medium (containing glucose at 50 g/l, yeast extract at 10 WI, peptone at 10 WI, sodium chloride at 5 g/l, and agar at 20 g/l, pH 7.0). One loopful cells of the resulting microbial cells was inoculated into a 500 ml Sakaguchi flask containing 50 ml of CM2G liquid medium (the aforementioned medium excluding agar) followed by shake culture at 25° C.
(2) Preparation of Chromosomal DNA from Microbial Cells
50 ml of culture solution was centrifuged (12,000 rpm, 4° C., 15 minutes) to recover the microbial cells. A chromosomal DNA was then obtained from the microbial cells using the Qiagen Genomic-Tip System (supplied from Qiagen) based on the procedure described in the manual therefor.
A DNA fragment containing a gene for portion of the peptide-synthesizing enzyme derived from Empedobacter brevis strain FERM BP-8113 was obtained by the PCR method using LA-Taq (supplied from Takara Shuzo). A PCR reaction was then carried out by using primers having the nucleotide sequences of SEQ ID NOs: 11 and 12 to the chromosomal DNA obtained from Empedobacter brevis strain FERM BP-8113.
The PCR reaction was carried out by using the Takara PCR Thermal Cycler—PERSONAL (Takara Shuzo) for 30 cycles under the following conditions.
After completion of the reaction, 3 μl of reaction mixture was applied to 0.8% agarose electrophoresis. As a result, it was verified that a DNA fragment of about 1.5 kb was amplified.
(4) Cloning of Gene for Peptide-Synthesizing Enzyme from Gene Library
In order to obtain the full-length gene for peptide-synthesizing enzyme, southern hybridization was carried out by using the DNA fragment amplified in the aforementioned PCR procedure as a probe. The procedure of southern hybridization is explained in Molecular Cloning, 2nd edition, Cold Spring Harbor Press (1989).
The approximately 1.5 kb DNA fragment amplified by the aforementioned PCR procedure was separated by 0.8% agarose electrophoresis. The target band was then cut out and purified. This DNA fragment was labeled with digoxinigen as probe by using DIG High Prime (supplied from Boehringer-Mannheim) based on the procedure described in the manual therefor.
After allowing the chromosomal DNA of Sphingobacterium sp. obtained in the step (2) of the present Reference 2 to react with restriction enzyme SacI at 37° C. for 16 hours to completely digest the DNA, the resultant was electrophoresed on 0.8% agarose gel. From the agarose gel after the electrophoresis, the electrophoresed chromosomal DNA was blotted onto a positively charged Nylon membrane filter (supplied from Roche Diagnostics), followed by treatments consisting of alkali denaturation, neutralization, and immobilization. Hybridization was carried out by using EASY HYB (supplied from Boehringer-Mannheim). After pre-hybridizing the filter at 37° C. for 1 hour, the digoxinigen-labeled probe prepared as described above was added and hybridization was carried out at 37° C. for 16 hours. Subsequently, the filter was washed twice at 60° C. with 1×SSC containing 0.1% SDS.
Detection of bands that hybridized with the probe was carried out by using the DIG Nucleotide Detection Kit (supplied from Boehringer-Mannheim) based on the procedure described in the manual therefor. As a result, a roughly 3 kb band was successfully detected that hybridized with the probe.
5 μg of the chromosomal DNA prepared in the step (2) of the present Reference 1 was completely digested with SacI. About 3 kb of a DNA was separated by 0.8% agarose gel electrophoresis, the DNA was purified using the Gene Clean II Kit (supplied from Funakoshi), and dissolved in 10 μl of TE. 4 μl of the resulting solution and pUC118 treated with alkaline phosphatase (E. coli C75) at 37° C. for 30 minutes and at 50° C. for 30 minutes, after reaction with SacI at 37° C. for 16 hours to completely digest, were mixed and a ligation reaction was carried out by using the DNA Ligation Kit Ver. 2 (supplied from Takara Shuzo). 5 μl of this ligation reaction mixture and 100 μl of competent cells of Escherichia coli DH5α (supplied from Takara Shuzo) were mixed to transform the Escherichia coli. This was then applied to a suitable solid medium to produce a chromosomal DNA library.
To obtain full-length gene for peptide-synthesizing enzyme, the chromosomal DNA library was screened by colony hybridization using the aforementioned probe. The procedure for colony hybridization is explained in Molecular Cloning, 2nd edition, Cold Spring Harbor Press (1989).
The colonies of the chromosomal DNA library were transferred on a Nylon membrane filter (Nylon Membrane for Colony and Plaque Hybridization, supplied from Roche Diagnostics), followed by treatments of alkali denaturation, neutralization, and immobilization. Hybridization was carried out by using EASY HYB (supplied from Boehringer-Mannheim). After pre-hybridizing the filter at 37° C. for 1 hour, the aforementioned digoxinigen-labeled probe was added, followed by hybridization at 37° C. for 16 hours. Subsequently, the filter was washed twice at 60° C. with 1×SSC containing 0.1% SDS.
Detection of colonies hybridizing with the labeled probe was carried out by using the DIG Nucleotide Detection Kit (supplied from Boehringer-Mannheim) based on the explanation described in the manual therefor. As a result, six strains of colonies were verified to have hybridized with the labeled probe.
(5) Nucleotide Sequence of Gene for Peptide-Synthesizing Enzyme Derived from Sphingobacterium sp.
Plasmids possessed by Escherichia coli DH5α were prepared from the six strains of microbial cells that were verified to have hybridized with the labeled probe by using the Wizard Plus Minipreps DNA Purification System (supplied from Promega) to determine the nucleotide sequence of a portion where hybridization with the probe occurred and nearby was determined. The sequencing reaction was carried out by using the CEQ DTCS-Quick Start Kit (supplied from Beckman-Coulter) based on the procedure described in the manual therefor. In addition, electrophoresis was carried out by using the CEQ 2000-XL (supplied from Beckman-Coulter).
As a result, it revealed that an open reading frame that encodes peptide-synthesizing enzyme did exist. The full-length nucleotide sequence of the gene for peptide-synthesizing enzyme derived from Sphingobacterium sp. along with the corresponding amino acid sequence is shown in SEQ ID NO: 19. Peptide-synthesizing enzyme derived from Sphingobacterium sp. exhibited a homology of 63.5% at the amino acid sequence level to the peptide-synthesizing enzyme derived from Empedobacter brevis (as determined using the BLASTP program).
(6) Expression of Gene for Peptide-Synthesizing Enzyme Derived from Sphingobacterium sp. in Escherichia coli
The target gene was amplified by PCR using the chromosomal DNA of Sphingobacterium sp. FERM BP-8124 as a template and the oligonucleotides shown in SEQ ID NOs: 21 and 22 as primers. This DNA fragment was treated with NdeI/XbaI, and the resulting DNA fragment and an NdeI/XbaI treatment product of pTrpT were ligated. Escherichia coli JM109 was then transformed with this ligation solution, and strains having the target plasmid were selected from ampicillin-resistant strains. The plasmid was designated as pTrpT_Sm_aet.
Escherichia coli JM109 having pTrpT_Sm_aet was cultivated at 25° C. for 20 hours by inoculating one loopful cells thereof into an ordinary test tube containing 3 ml of a medium (glucose 2 g/l, yeast extract 10 g/l, casamino acids 10 g/l, ammonium sulfate 5 g/l, potassium dihydrogen phosphate 3 g/l, dipotassium hydrogen phosphate 1 g/l, magnesium sulfate heptahydrate 0.5 g/l and ampicillin 100 mg/l). It was verified that a cloned gene having an α-AMP production activity of 0.53 U per ml of culture solution was expressed by Escherichia coli. Furthermore, no activity was detected for a transformant containing only pTrpT used as a control.
When the amino acid sequence of SEQ ID NO: 20 described in the Sequence Listing was analyzed with the Signal P v 1.1 program (Protein Engineering, Vol. 12, No. 1, pp. 3-9, 1999), it was predicted that amino acids numbers 1 to 20 function as a signal that is secreted into the periplasm, while the mature protein was estimated to be downstream of amino acid number 21.
One loopful cells of Escherichia coli JM109, having pTrpT_Sm_aet, was inoculated into ordinary test tubes containing 50 ml of a medium (glucose 2 g/l, yeast extract 10 g/l, casamino acids 10 g/l, ammonium sulfate 5 g/l, potassium dihydrogen phosphate 3 g/l, dipotassium hydrogen phosphate at 1 WI, magnesium sulfate heptahydrate 0.5 g/l and ampicillin 100 mg/l) and main cultivation was performed at 25° C. for 20 hours.
Hereinafter, procedures after centrifugal separation were carried out either on ice or at 4° C. After the cultivation, the microbial cells were separated from the culture solution by centrifugation, washed with 100 mM phosphate buffer (pH 7), and then suspended in the same buffer. The microbial cells were then subjected to ultrasonic disrupting treatment for 20 minutes at 195 W, the ultrasonic disrupted solution was centrifuged (12,000 rpm, 30 minutes) to remove the debris and obtain a soluble fraction. The resulting soluble fraction was applied to a CHT-II column supplied from Biorad) pre-equilibrated with 100 mM phosphate buffer (pH 7), and enzyme was eluted at a linear concentration gradient with 500 mM phosphate buffer. A solution obtained by mixing the active fraction with 5-fold volumes of 2 M ammonium sulfate and 100 mM phosphate buffer was applied to a Resource-PHE column (supplied from Amersham) pre-equilibrated with 2 M ammonium sulfate and 100 mM phosphate buffer, and an enzyme was eluted at a linear concentration gradient by 2 to 0 M ammonium sulfate to obtain an active fraction solution. As a result of these procedures, it was verified that the peptide-synthesizing enzyme was electrophoretically uniformly purified.
When the amino acid sequence of the aforementioned peptide-synthesizing enzyme was determined by Edman's decomposition method, the amino acid sequence of SEQ ID NO: 15 was obtained, and the mature protein was verified to be downstream of amino acid number 21 as was predicted by the SignalP v 1.1 program. Example 4 Production of alanylglutamine by the strain derived from Empedobacter aerogenes with amino acid ester transpeptidase highly expressed in the host, each of peptidase deficient strains
The plasmid pTrpT-aet derived from Empedobacter brevis for expressing amino-acid ester transpeptidase, which was constructed in the aforementioned Reference 1, was introduced by electroporation into the Escherichia coli JM109 strain, and the pepD-pepE double deficient strain and pepD-pepE-pepA triple deficient strain produced in Example 1 Each of strains was cultivated in the L-agar medium containing ampicillin (100 μg/mL) at 20° C. for 48 hours. Then, a ¼-plate allot of cells were transferred in 50 ml of L-medium (10 g/L of peptone, 5 g/L of yeast extract, 10 g/L of NaCl). Using a shaker (140 rpm), 3 ml of culture solution (OD610=0.15, 26-fold diluted), which was cultivated at 22° C. for 16 hours, was applied to 300 ml of medium with the composition shown below, followed by batch-cultivating in an experimental fermenter with 1.0 L of capacity while staring air flow (1/1 vvm) at 700 rpm. 15 ml of culture solution after sugar lost (OD610=0.60, 51-fold diluted) was applied into 300 ml of medium with the same composition and cultivated in the same fermenter at 20° C. while staring air flow (1/1 vvm) and feeding sugar. The pH value was automatically adjusted to 7.0 with gaseous ammonium.
Composition of medium (g/L):
Glucose 25.0
MgSO4.7H2O 1.0
(NH4)2SO4 5.0
H3PO4 3.5
FeSO4.7H2O 0.05
MnSO4.5H2O 0.05
Mameno (TN) 0.45
GD113 0.1
ampicillin 0.1
Glucose and magnesium sulfate were separately sterilized. The pH values for other components were adjusted to 5.0 by KOH.
Composition of feeding liquid sugar(g/L)
Glucose 500.0
pH not-adjusted
2 ml of culture solution was centrifuged (2200×g 15 min) to obtain the microorganism precipitates. 2 ml of physiological saline was added to the microorganism cell precipitates, followed by centrifugation (2200×g 15 min) to obtain the washed microorganism cells. The washed microorganism cells was added into 10 ml of reaction mixture containing 100 mM of L-alanine-methyl ester hydrochloride (14.0 mg/ml), 200 mM of L-glutamine (14.6 mg/ml)(0.2M), 100 mM of boric acid-NaOH buffer (pH9.0) and the alanylglutamine production reaction was induced under the conditions, pH 9.0 and 25° C. The result is shown in FIG. 1.
The initial velocity of the reaction was almost the same. However, in the reaction using the microorganisms, for which the host was the Escherichia coli JM109 strain, alanylglutamine was further dissolved as the reaction time was extended. In the reaction using the pepD-pepE double deficient strain and the pepD-pepE-pepA triple deficient strain as the hosts, even through the reaction time was extended, the decomposition of formed alanylglutamine was suppressed. In the actual production reaction, it is difficult to check the termination point, at which the reaction rapidly stops. Accordingly, it might be preferable to use the pepD-pepE double deficient strain or pepD-pepE-pepA triple deficient strain as the hosts for alanylglutamine production.
Although the invention has been described with respect to a specific embodiment for a complete and clear disclosure, the appended claims are not to be thus limited but are to be construed as embodying all modifications and alternative constructions that may occur to one skilled in the art which fairly fall within the basic teaching herein set forth.
SEQ ID NO: 1; PCR primer
SEQ ID NO: 2; PCR primer
SEQ ID NO: 3; PCR primer
SEQ ID NO: 4; PCR primer
SEQ ID NO: 5; PCR primer
SEQ ID NO: 6; PCR primer
SEQ ID NO: 7; PCR primer
SEQ ID NO: 8; PCR primer
SEQ ID NO: 9; amino acid sequence of enzyme determined by Edman degradation derived from Embedobacter brevis
SEQ ID NO: 10; amino acid sequence of enzyme determined by Edman degradation derived from Embedobacter brevis
SEQ ID NO: 11; mix primer
SEQ ID NO: 12; mix primer
SEQ ID NO: 13; peptide-synthesizing enzyme derived from Embedobacter brevis
SEQ ID NO: 14; peptide-synthesizing enzyme derived from Embedobacter brevis
SEQ ID NO: 15; primer for pTrpT preparation
SEQ ID NO: 16; primer for pTrpT preparation
SEQ ID NO: 17; primer for pTrpT_Gtg2 preparation
SEQ ID NO: 18; primer for pTrpT_Gtg2 preparation
SEQ ID NO: 19; peptide-synthesizing enzyme derived from Sphingobacterium SP
SEQ ID NO: 20; peptide-synthesizing enzyme derived from Sphingobacterium SP
SEQ ID NO: 21; primer for pTrpT_Sm_aet preparation
SEQ ID NO: 22; primer for pTrpT_Sm_aet preparation
| Number | Date | Country | Kind |
|---|---|---|---|
| 2004-029844 | Feb 2004 | JP | national |
| Number | Date | Country | |
|---|---|---|---|
| 60617060 | Oct 2004 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 11050829 | Feb 2005 | US |
| Child | 12828772 | US |
